Guardant Health

Cancer care often lacks timely, minimally invasive molecular information to guide diagnosis, treatment selection, and monitoring.

The company provides proprietary blood-based liquid biopsy tests combined with large data sets and advanced analytics to detect and profile cancer and track treatment response.

Oncologists and healthcare systems (and associated clinical labs) use these tests to manage cancer patients across the treatment journey.